A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement therapy in Lung Transplantation
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Lung transplant rejection
- Focus Therapeutic Use
- 24 Jul 2019 Planned End Date changed from 31 Aug 2020 to 1 Aug 2021.
- 24 Jul 2019 Status changed from not yet recruiting to recruiting.
- 24 Aug 2018 New trial record